Top Analyst Upgrades & Downgrades (ADSK, DG, GTIV, HUM, JEF, LVS, ORCL, OREX, HOT, TOT, VRSN, WYNN, YNDX)

These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls.

Autodesk, Inc. (NASDAQ: ADSK) Raised to Overweight at JPMorgan.
Dollar General Corporation (NYSE: DG) Started as Hold at Deutsche Bank.
Gentiva Health Services Inc. (NASDAQ: GTIV) named Bear of the Day at Zacks.
Humana, Inc. (NYSE: HUM) named Bull of the Day at Zacks.
Jefferies Group Inc. (NYSE: JEF) Cut to Neutral at Ticonderoga.
Las Vegas Sands Corp. (NYSE: LVS) Started as Buy at Deutsche Bank.
Oracle Corporation (NASDAQ: ORCL) Reiterated Buy with $32 target at BofA/ML; maintained Buy with $38 target at Canaccord Genuity.
Orexigen Therapeutics, Inc. (NASDAQ: OREX) Raised to Outperform at Leerink Swann; Maintained Neutral but target raised to $4 from $2 at BofA/ML.
Starwood Hotels & Resorts Worldwide Inc. (NYSE: HOT) Started as Buy at Deutsche Bank.
Total SA (NYSE: TOT) Raised to Neutral at Credit Suisse.
VeriSign Inc. (NASDAQ: VRSN) Cut to Neutral at JPMorgan.
Wynn Resorts Ltd. (NASDAQ: WYNN) Started as Buy at Deutsche Bank.
Yandex N. V. (NASDAQ: YNDX) Started as Buy at Jefferies.

 

“The Next NVIDIA” Could Change Your Life

NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.

But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.

The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”

The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below

Get Report Now — Its Free >>

Check Your Email! “The Next NVIDIA” Report is Being Sent to Your Inbox Right Now

By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.